1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About Abbott Laboratories

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Its portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 109,000 colleagues serve people in more than 160 countries.
Robert Ford

100 Abbott Park Rd
Abbott Park, Illinois 60064-3500
Phone: 12246676100


Barclays cuts Abbott Labs stock target, maintains Overweight
Apr 22, 2024 16:34pm


3 Dividend Kings Down 11% You’ll Regret Not Buying on the Dip
Apr 22, 2024 12:00pm

Dividend stocks have a proven record of stock market outperformance. For nearly 100 years, income-generating stocks on the S&P 500 have beaten non-payers. There has never been a decade when dividend stocks didn’t produce a positive return. And then we have the dividend royalty, companies that have raised their payouts the longest. These Dividend Kings have increased their dividends every year for 50 years or more without fail. Through wars, recessions and global pandemics, these businesses kept rewarding their investors for sticking by them. That doesn’t mean, however, their stocks will always go up. Economic factors and global events can temporarily slow business, causing investors to seek out faster growing stocks. But over time the Dividend Kings always rebound, explaining why they can still claim their thrones. The following are three royal dividend payers whose stocks are down 10% or more this year. You might want to consider buying these dividend stocks before they rebound once more.

Why I Believe Abbott Is Much Better Positioned In Today''s Rising Inflation Scenario
Apr 22, 2024 05:16am

Abbott Laboratories'' core business remains robust, with impressive performance across its segments. See why ABT stock is a Buy.

Source:Seeking Alpha
FDA recalls Abbott heart pumps linked to deaths, injuries
Apr 20, 2024 10:30am

The HeartMate 3 is a mechanical pump designed for patients with end-stage heart failure and manufactured by Thoratec Corp., a subsidiary of Abbott Laboratories of North Chicago. Known as a left ventricular assist device, the HeartMate 3 helps the main pumping chamber of the heart pump blood to the rest of the body. The device can be used by patients awaiting a heart transplant or for long-term therapy. The device is powered by a cable that is attached to the pump and exits the body through a surgical opening and connects to a controller and batteries or other power source, according to the manufacturer’s instruction manual. Abbott Laboratories instruction manual A pair of heart devices manufactured by a subsidiary of North Chicago-based Abbott Laboratories has received the FDA’s most serious recall after being linked to hundreds of injuries and at least 14 deaths, the agency has announced . The recall comes years after surgeons say they first noticed problems with the HeartMate II and HeartMate 3, manufactured by Thoratec Corp., an Abbott subsidiary.

Source:Chicago Sun-Times
Should You Expect Accelerating Earnings Growth for Abbott Laboratories (ABT)?
Apr 19, 2024 13:44pm

Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” first quarter 2024 investor letter. A copy of the same can be downloaded here. The US stock market started 2024 optimistically. In the first quarter, the fund returned 8.29% (gross) and 8.09% (net) compared to 11.41% for the Russell 1000 Growth Index and […]

Source:Insider Monkey
Abbott Laboratories (ABT) Q1 2024 Earnings: Exceeds Analyst Estimates and Raises Full-Year Guidance
Apr 18, 2024 17:54pm

Abbott Laboratories (ABT) Q1 2024 Earnings: Exceeds Analyst Estimates and Raises Full-Year Guidance

Citi maintains stock target on Abbott Labs with Buy rating on strong Q1 performance
Apr 18, 2024 16:13pm


Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations ...
Apr 18, 2024 07:01am

Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations and Raising Guidance

Abbott Labs'' surprise guidance bump is a major positive for its shareholders
Apr 17, 2024 18:33pm

We also love that EPS results on Tuesday came in above the range management had forecasted.

Abbott Labs Stock Falls as Q2 Guidance Outweighs Earnings Beat
Apr 17, 2024 17:59pm

Abbott Laboratories'' first-quarter earnings on Wednesday exceeded analyst expectations, but its stock fell after the company gave current-quarter guidance mostly below estimates.